Veracyte 2026年季度报告

FORM10-Q (Mark One)☒QUARTERLY REPORT PURSUANT TO SECTION13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026OR VERACYTE, INC.(Exact name of registrant as specified in its charter) 20-5455398 (State or other jurisdiction ofincorporation or organization) 6000 Shoreline Court, Suite 300South San Francisco, California 94080(Address of principal executive offices, zip code) (650)243-6300(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on whichregistered The Nasdaq Stock Market LLC Common Stock, par value, $0.001 per share Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or 15(d)of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and(2)has been subject to such filing requirements for the past 90 days. YesNo Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that theregistrant was required to submit such files). YesNo Table of Contents Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reportingcompany," and "emerging growth company" in Rule12b-2 of the Exchange Act. Large accelerated filerAccelerated filerNon-accelerated filerSmaller reporting companyEmerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Indicate by check mark whether the registrant is a shell company (as defined in Rule12b-2 of the Exchange Act). Yes☐No As of May1, 2026, there were 79,792,647 shares of common stock, par value $0.001 per share, outstanding. VERACYTE,INC.INDEX PARTI. — FINANCIAL INFORMATIONItem 1. Condensed Consolidated Financial Statements (Unaudited)Condensed Consolidated Balance Sheets as of March 31, 2026and December31, 2025Condensed Consolidated Statements of Operations for the Three Month Periods Ended March31, 2026 and 2025Condensed Consolidated Statements of Comprehensive Income for the Three Month PeriodsEnded March 31, 2026 and 2025Condensed Consolidated Statements of Stockholders' Equity for the Three Month PeriodsEnded March 31, 2026 and 2025Condensed Consolidated Statements of Cash Flows for the Three Month Periods EndedMarch 31, 2026 and 2025Notes to Condensed Consolidated Financial StatementsItem 2. Management’s Discussion and Analysis of Financial Condition and Results ofOperationsItem 3. Quantitative and Qualitative Disclosures About Market RiskItem 4. Controls and ProceduresPARTII. — OTHER INFORMATIONItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 2. Unregistered Sales of Equity Securities and Use of ProceedsItem 3. Defaults Upon Senior SecuritiesItem 4. Mine Safety DisclosuresItem 5. Other InformationItem 6. ExhibitsSIGNATURES VERACYTE,INC. SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q, or this report, contains forward-looking statements within the meaning of the Private SecuritiesLitigation Reform Act of 1995. All statements contained in this report other than statements of historical fact, including statementsconcerning our business strategy and plans, future operating results and financial position, as well as our objectives and expectations for ourfuture operations, are forward-looking statements. In some cases, you can identify forward-looking statements by such terminology as “believe,” “may,” “will,” “potentially,” “expect,”“estimate,” “continue,” “ongoing,” “anticipate,” “intend,” “could,” “would,” “project,” “plan,” “expect” or the negative of these terms orsimilar expressions that convey uncertainty of future events or outcomes, although not all forward-looking statements contain these words.These are statements that relate to future events and include, but are not limited to, statements about: •the factors that may impact our financial results;•our expectations regarding total revenue and total test volume;•our expectations with respect to our future research and development, general and administrative and selling and marketingexpenses and the anticipated uses of our funds;•the impact of macroeconomic conditions, including inflation, volatile interest rates and foreign exchange fluctuations; geopoliticaldevelopments, including regional and global conflicts, such as the ongoing conflict in the Middle East and the war in Ukraine;